TNF and cervical cancer: The first detailed study was conducted using the RNAi system and showed that Prx III inhibits the mitochondrial mPT and cytochrome c release in HeLa cervical cancer cells treated with tumor necrosis factor (TNF)-α and staurosporine [7].